Definitive Contract 75D30124C20135
Award Date
9/27/24
Potential Completion Date
9/29/25
Potential Value
$763K
Federal Agency
CDC Pittsburgh
Awardee
Biosearch Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Petaluma, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
The Centers for Disease Control and Prevention (CDC) awarded a $1,343,205.50 firm fixed-price contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide primer probes. This award was not set aside for any specific business type. Biosearch Technologies has a history of providing laboratory supplies like assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts for federal...
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for the delivery of primer probes. The contract is a Blanket Purchase Agreement (BPA) call valued at $626,838.00, with an ultimate completion date of July 30, 2022. Biosearch Technologies, through its LGC Biosearch Technologies division, is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. This...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $164,625.00. The contract is for the delivery of laboratory kits, with no set-aside designation. Biosearch Technologies, through its LGC Biosearch Technologies division, has provided a variety of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC's public health research and...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
The Centers for Disease Control and Prevention awarded a $799,986 firm fixed price modification to Biosearch Technologies, Inc. to produce an additional 1,020 vials of oligonucleotide primers and probes per ISO 13485 quality standards and Good Manufacturing Practices. The primers and probes have a specific internal BHQnova quencher design required for the FluSC2 Multiplex diagnostic assay approved under Emergency Use Authorization by the U.S. Food and Drug Administration. Delivery is required...
This federal contract award, valued at $249,997.00, was made by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a foreign-owned, for-profit manufacturer of oligonucleotide-based laboratory supplies and diagnostic testing components. The contract is for the provision of polymerase chain reaction (PCR) testing kits, with a period of performance running through April 24, 2025. Biosearch Technologies has a significant history as a federal contractor, having...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...